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Letters to the Editor 
Pseudobacteremia and 
Use of the Radiometric 
Blood Culture 
Analyzer 
To the Editor: 
We would like to report a further 
instance of pseudobacteremia that 
illustrates some additional considera-
tions in the use of the radiometric 
blood culture analyzer not discussed 
in two recent reports that appeared in 
Infection Control.1'2 
Our patient was a previously healthy 
6-week-old white male who presented 
to the University of Virginia Hospital 
with fever (38.8°C rectally), a fine mac-
ulopapular rash on the trunk, cheeks 
and extremities, and clear rhinorrhea. 
He was admitted for evaluation of the 
fever, and although our impression 
was that the infant had a viral illness, 
blood, urine and spinal fluid were 
cultured for bacteria. Initial labora-
tory analyses were normal, and the 
patient was treated empirically with 
gentamicin and ampicillin pending 
the results of the cultures, which we 
expected to be negative. On the sec-
ond hospital day, the blood culture was 
reported to be positive by radiometric 
detection, and a Gram stain of the 
culture broth showed gram-positive 
cocci. On the third hospital day, sub-
culture plates showed alpha hemolytic 
streptococci. The blood culture bottles 
immediately preceding our patient's 
cul ture in the r ad iome t r i c blood 
culture analyzer were noted to contain 
similar alpha hemolytic streptococci. 
The preceding blood cultures were 
from an adult with suspected subacute 
bacterial endocardi t is . Subsequent 
analysis of these two isolates showed 
that both were Streptococcus boms with 
iden t i ca l b iochemica l a n d an t i -
microbial sensitivity pat terns. The 
adul t had had mul t ip le positive 
cultures, and this information with the 
rarity of S. bovis as a pediatric patho-
gen convinced us that the organism 
had been transferred between cultures 
by the machine. Examination of the 
apparatus showed that the cavity sur-
rounding the needle sterilizer had not 
been routinely cleaned and contained 
debris left by the hollow-point needles 
after they penetrated the rubber sep-
tum of the culture bottle. In con-
sultation with the manufacturer the 
type of needle was changed to a solid-
point, less likely to produce debris, 
and routine cleaning of the heating 
block area was ins t i tu ted . Subse-
quently, measurement of the heater 
showed that it achieved only the mini-
mum specified temperature and it was 
replaced along with its control board. 
Because of the time required to 
identify the bacteria and to make the 
diagnosis of pseudobacteremia, the 
infant received six days of inappropri-
ate antibiotic therapy and excess hos-
pitalization. We believe this incident 
demonstrates that subtle defects in 
machine performance; in this case, 
probable needle sterilization failure 
on an intermittent basis may occur 
even when the routine maintenance is 
performed according to the manufac-
turer 's r e c o m m e n d a t i o n s and no 
actual deficiency can be identified in 
the apparatus. Because gram-positive 
cocci may be more resistant to heat 
than other bacteria3 these may be 
expected as cross-contaminants when 
needle-sterilization rout ine is only 
marginally adequate. If a more usual 
pathogen had been isolated in this 
blood culture, we may not have been 
able to differentiate this case from true 
bacteremia. Infection control practi-
tioners should be aware that the pos-
sibility of cross-contamination exists, 
even in the absence of easily identifia-
ble machine failure. Clinical laborato-
ries should maintain constant sur-
veillance of the relative position of 
positive blood cultures in the radi-
ometric detection device, and sus-
picious clusters should be thoroughly 
analyzed to investigate the possibility 
of cross-contamination. 
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Hepatitis B 
Immunization 
1983 to 1984 
To the Editor: 
With exposure to hepatitis B being a 
major health problem for high-risk 
employees in the hospital setting, Cra-
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ven County Hospital of New Bern, 
North Carolina elected to offer Hep-
tavax B (Hepatitis B Vaccine, Merck, 
Sharp & Dohme) to all employees in 
the high-risk groups free of charge. 
It was determined by the hospital 
Infection Control Committee that the 
following are considered high-risk 
employees: all registered nurses start-
ing intravenous therapy, all laboratory 
personnel, all operating room, recov-
ery room and anesthesia personnel, 
all emergency room staff, all Emer-
gency Medical Services personnel, 
and all invasive diagnostic and thera-
peutic services technicians. 
Hospitalwide inservice was con-
ducted, educating all high-risk staff 
members of the incidence of hepatitis 
B, what our immunization program 
included and the benefits to the staff 
and to patients. The inservice was 
given by our infection control nurse 
and a Merck, Sharp & Dohme repre-
sentative in February 1983. 
Initial screening (hepatitis B core 
AB and hepatitis B surface AB) was 
offered to all staff in these high-risk 
groups with 459 people taking advan-
tage of the screening. Two hundred 
seventy staff members have received 
the vaccine to date. 
Screened 
Received Vaccine 
Waivered 
Immune 
Pregnant Employees 
Resigned Prior to Vaccine 
Misc. not Receive Vaccine 
Not Vaccinated to Date 
459 
270 
19 
24 
29 
32 
11 
74 
Total 189 + 270 = 459 
During our initial screening one 
employee was detected as having an 
active case of hepatitis B. The Work-
mans C o m p e n s a t i o n costs were 
$4,362 plus $1,300 paid sick leave. 
Medical bills included over $2,600 for 
hospitalization and $1,200 in doctor's 
fees. If our hospital was to have one 
additional case of work-related hepati-
tis B, we could easily pay more in com-
pensation than what was spent in one 
primary immunization program. 
Our Employee Exposure to Hepati-
tis and Needlestick Protocol when 
source is known a n d u n k n o w n 
includes HBsAG and And HBs from 
the employee. This expense has been 
eliminated totally by our screening 
and immunization program. 
Total cost of detected case of hepatitis 
B —$8,862.00 
INFECTION CONTROL 1984/Vol. 5, No. 6 
Total cost of immunization program 
to date —$32,952.15 
Minus savings of one work-related case 
— $8,862.00 
Three-month savings on needlestick 
treatment — $1,290.00 
Our staff was receptive to the immu-
nization with 60% of those screened 
receiving the vaccine and less than 5% 
of those screened electing to sign a 
waiver. 
Of the 270 persons immunized, 
Heptavax B proved to be well-toler-
ated with only those side effects listed 
in the literature being elicited in few 
cases. 
As a partial result of our successful 
immunization program, several physi-
cian's offices and dental offices in the 
area have begun immunization pro-
grams for their staff members. 
In our hospital, the benefit of 
dec reased risk to pa t i en t s and 
employees greatly outweighed the cost 
of the immunization. 
Jane E. Santimaw, RN 
Employee Health Nurse 
Craven County Hospital Corporation 
New Bern, North Carolina 
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Brevis Isolation Cards and Labels instantly communicate CDC infection control precautions. 
Brevis, the first sign of 
good patient care. 
There isn't a single infection 
that you can't fight more effectively with 
the help of Brevis. That's because 
Brevis offers the most complete line of 
Isolation Cards and Labels now 
available to infection control 
professionals. 
Now the entire Brevis line has 
been updated to make it easier for the 
health care staff, patients and visitors 
to understand and follow CDC's 
"Guideline for Isolation Precautions in 
Hospitals" (Infection Control, Vol. 
4/No. 4). Included are the new 
"Disease-Specific Isolation 
Precautions" cards. 
Bigger. Bolder. Easier to read. 
Each card has been enlarged to 
6" x 10" with bigger and bolder 
variable pictograms. Constant symbols 
for hand washing and waste disposal 
instructions are displayed in the lower 
corners of each card. 
The largest type on each card 
is reserved for a VISITOR alert. 
Instructions are printed boldly in a 
white band across the top of each card 
in English, Spanish and French. 
Isolation Labels are easy to use
. 
Brevis Isolation Labels are 
miniature versions for use on patient 
chart covers and card files. They affix 
firmly to all surfaces and peel off 
easily. "Biohazard" and "Isolation 
Precaution" labels are also available for 
tagging waste bags and lab specimens
. 
A specially designed aluminum rack 
keeps labels organized for easy 
dispensing. 
Comprehensive. Inexpensive. 
The Brevis line of Nursing 
Cards is now also available printed on 
the back of Category-Specific Isolation 
cards (for extra flexibility). These 
reusable cards feature a UV plastic 
coating for greater readability and 
longer life. This exclusive Brevis 
feature saves money because it cuts 
inventory requirements in half. 
In fact, Brevis can help you 
control infection for far less than you 
might expect. 
Send for a FREE Sample Pack. 
Use this handy coupon to order 
your free Brevis Sample Pack. It 
comes complete with representative 
products from the latest Brevis line. 
Beat the bugs. Fight infection 
more effectively with Brevis. 
Brevis, Inc., 
4305 Brockbank Way, 
Salt Lake City, Utah 84124 
(801) 278-0670 
NAME. 
TITLE. 
HOSPITAL. 
ADDRESS 
CITY 
STATE, ZIP. 
https:/www.cambridge.org/core/terms. https://doi.org/10.1017/S019594170006029X
Downloaded from https:/www.cambridge.org/core. University of Basel Library, on 11 Jul 2017 at 11:15:31, subject to the Cambridge Core terms of use, available at
